1. Home
  2. KOD vs SXTC Comparison

KOD vs SXTC Comparison

Compare KOD & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • SXTC
  • Stock Information
  • Founded
  • KOD 2009
  • SXTC 2005
  • Country
  • KOD United States
  • SXTC China
  • Employees
  • KOD N/A
  • SXTC N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • SXTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOD Health Care
  • SXTC Health Care
  • Exchange
  • KOD Nasdaq
  • SXTC Nasdaq
  • Market Cap
  • KOD 198.4M
  • SXTC 186.8M
  • IPO Year
  • KOD 2018
  • SXTC 2019
  • Fundamental
  • Price
  • KOD $10.57
  • SXTC $1.60
  • Analyst Decision
  • KOD Hold
  • SXTC
  • Analyst Count
  • KOD 4
  • SXTC 0
  • Target Price
  • KOD $11.25
  • SXTC N/A
  • AVG Volume (30 Days)
  • KOD 681.7K
  • SXTC 72.8K
  • Earning Date
  • KOD 08-13-2025
  • SXTC 01-01-0001
  • Dividend Yield
  • KOD N/A
  • SXTC N/A
  • EPS Growth
  • KOD N/A
  • SXTC N/A
  • EPS
  • KOD N/A
  • SXTC N/A
  • Revenue
  • KOD N/A
  • SXTC $1,740,907.00
  • Revenue This Year
  • KOD N/A
  • SXTC N/A
  • Revenue Next Year
  • KOD N/A
  • SXTC N/A
  • P/E Ratio
  • KOD N/A
  • SXTC N/A
  • Revenue Growth
  • KOD N/A
  • SXTC N/A
  • 52 Week Low
  • KOD $1.92
  • SXTC $0.95
  • 52 Week High
  • KOD $11.60
  • SXTC $8.64
  • Technical
  • Relative Strength Index (RSI)
  • KOD 77.63
  • SXTC 48.26
  • Support Level
  • KOD $7.69
  • SXTC $1.55
  • Resistance Level
  • KOD $8.45
  • SXTC $1.66
  • Average True Range (ATR)
  • KOD 0.83
  • SXTC 0.10
  • MACD
  • KOD 0.17
  • SXTC 0.01
  • Stochastic Oscillator
  • KOD 85.66
  • SXTC 45.83

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: